BAM
ASTH icon

Belpointe Asset Management’s Astrana Health ASTH Stock Holding History

Belpointe Asset Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20
Closed -$729 – 3466
2023
Q1 		$729 Buy
+20
New +$700 ﹤0.01% 3532

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Belpointe Asset Management's ASTH Position: Q2 2023 in Review

Belpointe Asset Management sold out of Astrana Health (ASTH) in Q2 2023, closing a stake of 20 shares — an estimated $729 sold.

Belpointe Asset Management first reported a position in ASTH in Q1 2023 and held it in 1 quarter. The position peaked at $729 in Q1 2023. 130 funds tracked by Wall St. Rank hold ASTH as of Q2 2023.

  • Belpointe Asset Management reported no remaining Astrana Health position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 20 Astrana Health shares in Q2 2023, an estimated $729.
  • Belpointe Asset Management first reported a position in Astrana Health in Q1 2023 and held it in 1 quarter.
  • Belpointe Asset Management's Astrana Health position peaked at $729 in Q1 2023.
  • 130 funds tracked by Wall St. Rank held Astrana Health as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.